Minor Suspected

Description

Memantine may compete with metformin for renal tubular cationic secretion, potentially increasing metformin plasma concentrations modestly.

Mécanisme

Memantine and metformin are both organic cation transporter (OCT) substrates and are eliminated via renal tubular secretion; competition at OCT2 may reduce metformin clearance.

Signification clinique

The interaction is generally minor but may be relevant in patients with renal impairment where both drug accumulations could be additive.

Prise en charge

Monitor renal function and blood glucose in patients taking both drugs, especially if renal function declines.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.